Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12291-021-00986-x http://scihub22266oqcxt.onion/10.1007/s12291-021-00986-x 34177138!8212795!34177138     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Indian+J+Clin+Biochem 2021 ; 36 (4): 485-491 Nephropedia Template TP {{tp|p=34177138|t=2021. Combined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 Patients in India |pdf=|usr=}}{{34177138}} gab.com Text Combined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 Patients in India JO: Indian J Clin Biochem http://www.kidney.de/pget.php?&tw=1&pmid=34177138 #FOAvip Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a global health problem, India being the second most affected country. The kinetics of antibody response to SARS-CoV-2 in Indian population is not studied yet. To understand serological response in relation to age, gender, time period and severity of disease, Roche Elecsys anti-SARS-CoV-2 test was used which analysed both IgM and IgG. One hundred and three COVID-19 patients were enrolled. Seropositivity was seen in 64% of patients, with 33% at </= 7 days, 62% between 8 and 15 days and 81% at >/= 16 days from the time of admission. Men (65%) showed higher antibody response than women (59%), whereas no difference was observed in seropositivity with respect to age of the patients. Dynamics of antibody responses revealed individual variations. Patients in ICU had higher antibody reactivity with 67% positivity as compared to 60% positivity in non-ICU patients. Kinetics of antibody response during COVID-19 disease varied in relation to gender, age, time period and severity and these factors might play an important role in treatment and control of COVID-19. Twit Text FOAVip Combined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 Patients in India ????Indian J Clin Biochem http://www.kidney.de/pget.php?&tw=1&pmid=34177138 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34177138 #FOAvip English Wikipedia <ref>{{Cite pmid|34177138}}</ref> Combined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 Patients in India #MMPMID34177138 Chidananda MK; Zohmangaihi D; Ram S; Soni SL; Suri V; Malhotra P; Jassal RS; Kaur J; Verma I; Sharma S Indian J Clin Biochem 2021[Oct]; 36 (4): 485-491 PMID34177138show ga Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a global health problem, India being the second most affected country. The kinetics of antibody response to SARS-CoV-2 in Indian population is not studied yet. To understand serological response in relation to age, gender, time period and severity of disease, Roche Elecsys anti-SARS-CoV-2 test was used which analysed both IgM and IgG. One hundred and three COVID-19 patients were enrolled. Seropositivity was seen in 64% of patients, with 33% at /= 16 days from the time of admission. Men (65%) showed higher antibody response than women (59%), whereas no difference was observed in seropositivity with respect to age of the patients. Dynamics of antibody responses revealed individual variations. Patients in ICU had higher antibody reactivity with 67% positivity as compared to 60% positivity in non-ICU patients. Kinetics of antibody response during COVID-19 disease varied in relation to gender, age, time period and severity and these factors might play an important role in treatment and control of COVID-19. äCombined Analysis of Anti SARS-CoV-2 IgG and IgM Responses in COVID19 (epmc).pdf DeepDyve Pubget Overpricing